Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Welch Allyn Protocol, Inc. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

60 daysmedian FDA review time
131 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K070204LINK TO ACUITY CLINICIAN NOTIFIERWelch Allyn Protocol, Inc.2007-03-23600
K063419MODIFICATION TO VSM- VITAL SIGNS MONITOR, (VSM 300 )Welch Allyn Protocol, Inc.2006-12-04211
K033378VITAL SIGNS MONITOR, PROPAQ LTWelch Allyn Protocol, Inc.2004-03-011313
K031740VSM - VITAL SIGNS MONITOR, MODEL 53000 SERIESWelch Allyn Protocol, Inc.2003-08-26830
K022453MODIFICATION TO ACUITY CENTRAL MONITORING SYSTEMWelch Allyn Protocol, Inc.2002-08-21261
K021681MICROPAQ, MODELS 402, 404Welch Allyn Protocol, Inc.2002-07-23620
K012451PROPAQ ENCORE MODELS 202, 204, 206; PROPAQ CS MODELS 242, 24Welch Allyn Protocol, Inc.2001-08-20190

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda